Abstract
We present two cases of peripheral nerve schwannoma which showed an increased accumulation of 2-deoxy-[18F] fluoro-D-glucose (FDG) in the tumors on positron emission tomography (PET) imaging acquired at both 1 h (early phase) and 2 h (delayed phase) after FDG injection. FDG-PET scans were performed with a dedicated PET scanner (HeadtomeV/ SET2400 W, Shimadzu, Kyoto, Japan) and the PET data analyzed the most metabolically active region of interest (ROI). We set the maximum standardized uptake value (SUV max) with a cut-off point of 3.0 to distinguish benign and malignant lesions. Although the mechanism responsible for the increased FDG uptake in benign schwannomas remains unknown, we discuss our findings in the context of tumor cellularity and briefly review other studies on the subject.
Similar content being viewed by others
References
Hide IG, Baudouin CJ, Murray SA, Malcolm AJ. Giant ancient schwannoma of the pelvis. Skeletal Radiol 2000; 29:538–542.
Schindler OS, Dixon JH, Case P. Retroperitoneal giant schwannomas: report on two cases and review of the literature. J Orthop Surg (Hong Kong) 2002; 10:77–84.
Ogose A, Hotta T, Morita T, Yamamura S, Hosaka N, Kobayashi H, et al. Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol 1999; 28:183–188.
Ahmed AR, Watanabe H, Aoki J, Shinozaki T, Takagishi K. Schwannoma of the extremities: the role of PET in preoperative planning. Eur J Nucl Med 2001; 28:1541–1551.
Daneshmand S, Youssefzadeh D, Chamie K, Boswell W, Wu N, Stein JP, et al. Benign retroperitoneal schwannoma: a case series and review of the literature. Urology 2003; 62:993–997.
Lodge MA, Lucus JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of18FDG uptake in soft tissue masses. Eur J Nucl Med 1999; 26:22–30
Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med 1999; 26: 599–605.
Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging of tumor detection. Eur J Nucl Med 2001; 28:696–703.
Soderlund V, Goranson H, Bauer HC. MR imaging of benign peripheral nerve sheath tumors. Acta Radiol 1994; 35:282–286.
Lee JA, Boles CA. Peripheral schwannoma lacking enhancement on MRI. Am J Roentgenol 2004; 182:534–535.
Varma DG, Moulopoulos A, Sara AS, Leeds N, Kumar R, Kim EE, et al. MR imaging of extracranial nerve sheath tumors. J Comput Assist Tomogr 1992; 16:448–453.
Beggs I. Pictorial review: imaging of peripheral nerve tumours. Clin Radiol 1997; 52:8–17
Beaulieu S, Rubin B, Djang D, Conrad E, Turcotte E, Eary JF. Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. Am J Roentgenol 2004; 182:971–974.
Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32:623–648.
Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988; 29:181–186.
Aoki J, Watanabe H, Shinozaki T, Takagishi K, Tokunaga M, Koyama Y, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol 2003; 32:133–138.
Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991; 32:1508–1512.
Aoki J, Endo K, Watanabe H, Shinozaki T, Yanagawa T, Ahmed AR, et al. FDG-PET for evaluating musculoskeletal tumors: a review. J Orthop Sci 2003; 8:435–441.
Watanabe H, Inoue T, Shinozaki T, Yanagawa T, Ahmed AR, Tomiyoshi K, et al. PET imaging of musculoskeletal tumours with fluorine-18α- methyltyrosine: comparison with fluorine-18 fluoro-deoxyglucose PET. Eur J Nucl Med 2000; 27:1509–1517.
Magnani P, Thomas TP, Tennekoon G, DeVries GH, Greene DA, Brosiu FC III. Regulation of glucose transport in cultured Schwann cells. J Peripher Nerv Syst 1998; 3:28–36.
Waki A, Fujibayashi Y, Yokoyama A. Recent advances in the analyses of the characteristics of tumor on FDG uptake: mini review. Nucl Med Biol 1998; 25:589–592.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamada, K., Ueda, T., Higuchi, I. et al. Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging. Skeletal Radiol 34, 52–57 (2005). https://doi.org/10.1007/s00256-004-0845-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-004-0845-z